1 Product identity
Ingredient risk
1 ingredient to use with caution
Double Strength Saffron
BrandWindmill Health Products→Botanical Tablet or Pill 8 ingredients 1 caution DSLD #19017Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-03-25
2 Ingredients (8)
IngredientGroupSafety
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
CoatingCoating—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Saffron Extract — Limited Evidence
⚠ Toxic at 5+ g (abortifacient, hemorrhagic)
⚠ May enhance serotonergic drugs
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID19017
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-03-25
6 More from Windmill Health Products
View Windmill Health Products Safety Scorecard → 11 products
Chewable Vitamin D 400 IUGreen Coffee BeanNature's Aphrodisiac For WomenRaspberry SlimVITAdrops Gummies Adult Multi-VitaminsVITAdrops Gummies Children's DHA7 Cite this page
Vancouver
Pkhakadze G. Double Strength Saffron — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 27]. Available from: https://academy.gmj.ge/products/double-strength-saffron-19017/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG